Carlyle completed a $250m investment in Pharmapacks.

The Carlyle Group completed a $250m investment in Pharmapacks, an e-commerce enablement platform. The investment values Pharmapacks at $1.1bn. "Pharmapacks is experiencing unprecedented growth with massive market support and highly attractive industry dynamics. We are thrilled that our partnership with Carlyle, a world-class investment firm with extensive connectivity, data and global resources, will provide us with an opportunity to take significant steps to enter the next phase of our growth plans," Andrew Vagenas, Pharmapacks Chief Executive Officer.